Deal Library / Pharma BD Deal Intelligence

Valeant Pharmaceuticals International, Inc. — Pharma Deals

The Pharma Closeout tracks 5 deals, $4.6B in disclosed deal value, 4 with a post-close Outcome Score for Valeant Pharmaceuticals International, Inc..

Median Critic Score: 63  ·  Median Outcome Score: 34

Best outcome: Valeant Pharmaceuticals International, Inc. / iNova Pharmaceuticals (63)  ·  Weakest outcome: Valeant Pharmaceuticals International, Inc. / PreCision Dermatology, Inc. (23)

All 5 deals

• Valeant Pharmaceuticals International, Inc. / iNova Pharmaceuticals — 2011 · $700M · Largely worked — most objectives met.
• Valeant Pharmaceuticals International, Inc. / Dermik Laboratories (Sanofi dermatology unit) — 2011 · $425M · Underwhelmed — fell short of the thesis.
• Valeant Pharmaceuticals International, Inc. / Medicis Pharmaceutical Corporation — 2012 · $2.6B · Underwhelmed — fell short of the thesis.
• Valeant Pharmaceuticals International, Inc. / PreCision Dermatology, Inc. — 2014 · $475M · Did not work — the deal failed to deliver.
• Valeant Pharmaceuticals International, Inc. / Sanitas Group AB — 2011 · $440M

← Deal Library  ·  Interactive search  ·  How we score deals